170 related articles for article (PubMed ID: 38824552)
21. B cell-Derived IL35 Drives STAT3-Dependent CD8
Mirlekar B; Michaud D; Lee SJ; Kren NP; Harris C; Greene K; Goldman EC; Gupta GP; Fields RC; Hawkins WG; DeNardo DG; Rashid NU; Yeh JJ; McRee AJ; Vincent BG; Vignali DAA; Pylayeva-Gupta Y
Cancer Immunol Res; 2020 Mar; 8(3):292-308. PubMed ID: 32024640
[TBL] [Abstract][Full Text] [Related]
22. Myeloid suppressor cell depletion augments antitumor activity in lung cancer.
Srivastava MK; Zhu L; Harris-White M; Kar UK; Huang M; Johnson MF; Lee JM; Elashoff D; Strieter R; Dubinett S; Sharma S
PLoS One; 2012; 7(7):e40677. PubMed ID: 22815789
[TBL] [Abstract][Full Text] [Related]
23. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model.
Bauer C; Sterzik A; Bauernfeind F; Duewell P; Conrad C; Kiefl R; Endres S; Eigler A; Schnurr M; Dauer M
Cancer Immunol Immunother; 2014 Apr; 63(4):321-33. PubMed ID: 24384835
[TBL] [Abstract][Full Text] [Related]
24. CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
Choueiry F; Torok M; Shakya R; Agrawal K; Deems A; Benner B; Hinton A; Shaffer J; Blaser BW; Noonan AM; Williams TM; Dillhoff M; Conwell DL; Hart PA; Cruz-Monserrate Z; Bai XF; Carson WE; Mace TA
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581043
[TBL] [Abstract][Full Text] [Related]
25. Phosphatidyl Inositol 3 Kinase-Gamma Balances Antiviral and Inflammatory Responses During Influenza A H1N1 Infection: From Murine Model to Genetic Association in Patients.
Garcia CC; Tavares LP; Dias ACF; Kehdy F; Alvarado-Arnez LE; Queiroz-Junior CM; Galvão I; Lima BH; Matos AR; Gonçalves APF; Soriani FM; Moraes MO; Marques JT; Siqueira MM; Machado AMV; Sousa LP; Russo RC; Teixeira MM
Front Immunol; 2018; 9():975. PubMed ID: 29867955
[TBL] [Abstract][Full Text] [Related]
26. Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy.
Cook KW; Xue W; Symonds P; Daniels I; Gijon M; Boocock D; Coveney C; Miles AK; Shah S; Atabani S; Choudhury RH; Vaghela P; Weston D; Metheringham RL; Brentville VA; Durrant LG
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34321274
[TBL] [Abstract][Full Text] [Related]
27. Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
Saenger YM; Li Y; Chiou KC; Chan B; Rizzuto G; Terzulli SL; Merghoub T; Houghton AN; Wolchok JD
Cancer Res; 2008 Dec; 68(23):9884-91. PubMed ID: 19047169
[TBL] [Abstract][Full Text] [Related]
28. A CD40 Agonist and PD-1 Antagonist Antibody Reprogram the Microenvironment of Nonimmunogenic Tumors to Allow T-cell-Mediated Anticancer Activity.
Ma HS; Poudel B; Torres ER; Sidhom JW; Robinson TM; Christmas B; Scott B; Cruz K; Woolman S; Wall VZ; Armstrong T; Jaffee EM
Cancer Immunol Res; 2019 Mar; 7(3):428-442. PubMed ID: 30642833
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer.
Guo M; Luo B; Pan M; Li M; Xu H; Zhao F; Dou J
Int Immunopharmacol; 2020 Nov; 88():106850. PubMed ID: 32777675
[TBL] [Abstract][Full Text] [Related]
30. PI3Kγ Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells.
Azzi J; Thueson L; Moore R; Abdoli R; Reijonen H; Abdi R
PLoS One; 2017; 12(1):e0169695. PubMed ID: 28081180
[TBL] [Abstract][Full Text] [Related]
31. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.
Ene-Obong A; Clear AJ; Watt J; Wang J; Fatah R; Riches JC; Marshall JF; Chin-Aleong J; Chelala C; Gribben JG; Ramsay AG; Kocher HM
Gastroenterology; 2013 Nov; 145(5):1121-32. PubMed ID: 23891972
[TBL] [Abstract][Full Text] [Related]
32. Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
Baert T; Vankerckhoven A; Riva M; Van Hoylandt A; Thirion G; Holger G; Mathivet T; Vergote I; Coosemans A
Front Immunol; 2019; 10():1273. PubMed ID: 31214202
[TBL] [Abstract][Full Text] [Related]
33. IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma.
Blair AB; Kleponis J; Thomas DL; Muth ST; Murphy AG; Kim V; Zheng L
J Clin Invest; 2019 Apr; 129(4):1742-1755. PubMed ID: 30747725
[TBL] [Abstract][Full Text] [Related]
34. PI3K
Jin JR; Gogvadze E; Xavier AR; Bohnacker T; Voelzmann J; Wymann MP
Front Immunol; 2020; 11():585070. PubMed ID: 33193405
[TBL] [Abstract][Full Text] [Related]
35. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
[TBL] [Abstract][Full Text] [Related]
36. New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models.
Lopes A; Bastiancich C; Bausart M; Ligot S; Lambricht L; Vanvarenberg K; Ucakar B; Gallez B; Préat V; Vandermeulen G
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795383
[TBL] [Abstract][Full Text] [Related]
37. Generation of multiepitope cancer vaccines based on large combinatorial libraries of survivin-derived mutant epitopes.
Domínguez-Romero AN; Martínez-Cortés F; Munguía ME; Odales J; Gevorkian G; Manoutcharian K
Immunology; 2020 Oct; 161(2):123-138. PubMed ID: 32619293
[TBL] [Abstract][Full Text] [Related]
38. PI3Kγ is a molecular switch that controls immune suppression.
Kaneda MM; Messer KS; Ralainirina N; Li H; Leem CJ; Gorjestani S; Woo G; Nguyen AV; Figueiredo CC; Foubert P; Schmid MC; Pink M; Winkler DG; Rausch M; Palombella VJ; Kutok J; McGovern K; Frazer KA; Wu X; Karin M; Sasik R; Cohen EE; Varner JA
Nature; 2016 Nov; 539(7629):437-442. PubMed ID: 27642729
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer.
Li C; Cui L; Yang L; Wang B; Zhuo Y; Zhang L; Wang X; Zhang Q; Zhang S
Pancreas; 2020 Jan; 49(1):120-127. PubMed ID: 31856087
[TBL] [Abstract][Full Text] [Related]
40. Anti-PD1 antibody enhances the anti-tumor efficacy of MUC1-MBP fusion protein vaccine via increasing Th1, Tc1 activity and decreasing the proportion of MDSC in the B16-MUC1 melanoma mouse model.
Zhang Z; Zhou H; Liu Y; Ren J; Wang J; Sang Q; Lan Y; Wu Y; Yuan H; Ni W; Tai G
Int Immunopharmacol; 2021 Dec; 101(Pt A):108173. PubMed ID: 34607233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]